OMEICOS Therapeutics logo

OMEICOS Therapeutics jobs and careers

Berlin, Germany

About OMEICOS Therapeutics

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Founded in 2013 by Karen Uhlmann and Robert Fischer.

Founded
2013
Employees
11 to 50
Total funding
$37.3M
Headquarters
Berlin

Leadership

The top of OMEICOS Therapeutics's org chart, with how many people report into each leader.

RFPhoto of Robert Fischer

Robert Fischer

Co-Founder, CEO & CSO

8 reports

KUPhoto of Karen Uhlmann

Karen Uhlmann

Vice President Operations & IP

3 reports

EBPhoto of Edita Bade

Edita Bade

Head of Finance & Controlling

MHPhoto of Markus Henrich

Markus Henrich

Consultant, Medicinal Chemistry & CMC

SRPhoto of Simon Russell

Simon Russell

Chief Business Officer

DLPhoto of Dr. Dipl.-Ing. (FH) Martin Liss

Dr. Dipl.-Ing. (FH) Martin Liss

R&D Scientist

Board

CS

Christian Schneider

Board Member

PS

Peter Seiler

Board Member

TI

Taro Inaba

Board Member

WS

Wolf-Hagen Schunck

Board Member

BK

Bernhard Kirschbaum

Supervisory Board Chairman

Jobs at OMEICOS Therapeutics

No open positions right now. Explore more companies on TheJobsMap.